## Abstract To a limited extent, thrombotic thrombocytopenic purpura (TTP) in addition to its clinical features is being defined nowadays with laboratory tests such as the assay for the Von Willebrand factorβcleaving protease (ADAMTS 13) and its antibody. We present a case report of a patient with
Successful treatment of thrombotic thrombocytopenic purpura with repeated plasma exchange in a patient with microscopic polyangitis
β Scribed by Koji Nagai; Takuya Kotani; Tohru Takeuchi; Takeshi Shoda; Ayu Hata-Kobayashi; Daisuke Wakura; Maki Kagitani; Shigeki Makino; Toshiaki Hanafusa
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 168 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1439-7595
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Five patients with thrombotic thrombocytopenic purpura (TTP) were treated with corticosteroids, plasma exchange (PE), and antiplatelet agents. ABO-and Rh-compatible fresh-frozen plasma (FFP) was used as the replacement fluid. None of the patients received FFP infusion without PE. The patients were
The objective of this study was to assess the effect of protein A immunoabsorption in terms of response rate and toxicities in patients with classical thrombotic thrombocytopenic purpura (TTP) refractory to therapeutic plasma exchange. The study included nine females and one male with a diagnosis of